Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Revenue

Fusion Antibodies had revenue of 838.00K GBP in the half year ending September 30, 2025, with 54.90% growth. This brings the company's revenue in the last twelve months to 1.60M, down -11.43% year-over-year. In the fiscal year ending March 31, 2025, Fusion Antibodies had annual revenue of 1.97M with 72.98% growth.

• Revenue (ttm): 1.60M
• Revenue Growth: -11.43%
• P/S Ratio: 12.14
• Revenue / Employee: 66.50K
• Employees: 24
• Market Cap: 19.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.97M	829.00K	72.98%
Mar 31, 2024	1.14M	-1.77M	-60.84%
Mar 31, 2023	2.90M	-1.90M	-39.55%
Mar 31, 2022	4.80M	634.00K	15.22%
Mar 31, 2021	4.17M	270.00K	6.93%